COVID-19 Impact : Anti-Rheumatics Market to Witness Growth Acceleration During 2019-2026 - Pfizer, Johnson & Johnsons
Anti-rheumatics market accounted for $57,229 million in 2018 and is expected to reach $71,934 million by 2026, registering a CAGR of 2.9% from 2019 to 2026.
View full press release